Picture of Mesa Laboratories logo

MLAB — Mesa Laboratories News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Mesa Laboratories Inc expected to post earnings of 26  cents a share - Earnings Preview

* Mesa Laboratories Inc  MLAB.OQ   MLAB.O  is expected to show a
rise in quarterly revenue when it reports results on May 31
(estimated) .
* The Lakewood, Colorado-based company is expected to report   a
3.2% increase in revenue to $35.306 million from $34.21 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Mesa Laboratories Inc
is for earnings of 26 cents per share. For the same quarter last
year, the company reported earnings of 6 cents per share.
* The current average analyst rating on the shares is "hold" and
the breakdown of recommendations is 1 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Mesa
Laboratories Inc is $267.5​, about 8.1% above​ its last closing
price of $245.80. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Dec. 31 2020  0.32        0.33       -0.89     Missed  -373.8
 Sep. 30 2020  0.04        0.06       0.51      Beat    705.3
 Jun. 30 2020  0.89        0.76       0.22      Missed  -71.1​
 Mar. 31 2020  0.17        0.21       0.06      Missed  -71
 Dec.          1.29​       1.00       -1.06     Missed  -206.3
 31​ 2019​                                              ​
 Sep. 30 2019  0.80        0.81       0.71      Missed  -12​
 Jun. 30 2019  0.84        0.85       1.13      Beat    33.7
 Mar. 31 2019  1.08        1.08       0.34      Missed  -68.5
 This summary was machine generated May 28 at 12:30 GMT.  All
figures in US dollars unless otherwise stated

Recent news on Mesa Laboratories

See all news